May 5, 2014 Cellectar Biosciences Announces Receipt of Orphan Designation of I-124-CLR1404 as Diagnostic for the Management of Glioma from U.S. Food and Drug Administration Learn More
Apr 2, 2014 Dr. Simon Pedder Becomes President and Chief Executive Officer of Cellectar Biosciences Learn More
Mar 19, 2014 Cellectar Biosciences to Host Conference Call on March 25th to Discuss Full Year 2013 Financial Results and Provide Quarterly Update on Development Progress Learn More